I nterleukin-10 is a pleiotropic cytokine with multiple biological effects on various types of blood cells, including roles as a survival, proliferation, and differentiation factor for B cells (1, 2) . This was demonstrated most convincingly using human B cells, stimulated either via the IgRs or by a combination of CD40 Abs and IL-4. Under these conditions, IL-10 enhances DNA synthesis and expansion of activated B cells, as well as induces their differentiation into Ab-producing cells that secrete large amounts of IgM, IgG, and IgA Abs (3) (4) (5) . Patients with lupus, a disease closely linked to abnormal autoantibodies, have a high concentration of serum IL-10, with its level correlating with disease activity (6) (7) (8) (9) .
Despite the evidence suggesting that IL-10 promotes Ab production in humans, its complex role was first described in studies using rodent models. Its suppressive role is supported by data from IL-10-deficient mice. IL-10 deficiency accelerated lupus in MRLFas lpr mice (10) and arthritis induced by collagen (11) through a mechanism of increasing autoreactive IgG2a. Additionally, in an Il10 2/2 model of inflammatory bowel disease (IBD), increased levels of IgG and IgA were found in blood or target organs (12) . The data collectively reflect the opposing roles of IL-10 in humoral immunity in rodents, with the precise mechanism(s) of action largely unknown. Naive B cell differentiation into high-affinity memory B cells and long-lived plasma cells requires the help of CD4 + T cells. T follicular helper cells (T FH cells) that express chemokine CXCR5, which facilitates their entry into germinal centers (GCs), have recently been considered a key Th subset for B cell proliferation, somatic hypermutation of Ig variable-region gene segments, and class-switch recombination of Igs (13) . Furthermore, these T FH cell populations serve as an important reservoir of memory cells for secondary responses to Ags (14) . T FH cells provide help to B cells through several factors, including CD154 and ICOS (13) . In particular, T FH cells secrete the cytokine IL-21, which drives the growth, differentiation, and isotype switching of B cells (13) . Furthermore, IL-21 provides a positive-feedback loop to induce CD4 + T cells to differentiate into T FH cells (15) , a process demonstrated in both human and mouse CD4 + T cells. However, the possible influence of other cytokines on T FH cells is unknown. Because IL-10 inhibits effective T cell function in many autoimmune models, we wondered whether IL-10 regulated Ab production through a mechanism that affects T FH cells. To test this hypothesis, we studied the action of IL-10 on T FH cell function in vitro and in vivo.
Materials and Methods

Mice and adoptive transfers
Male 6-8-wk-old wild-type (WT) C57BL/6 (H-2 b ) mice and Rag1 2/2 mice (C57BL/6) were purchased from the Nanjing Model Animal Center (Nanjing, China). Il10rb 2/2 mice (C57BL/6) were obtained from The Jackson Laboratory. Mice were maintained in a specific pathogen-free animal facility and handled in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health.
For adoptive transfers, Rag1 2/2 mice were given 2 3 10 6 purified CD4 
Immunization of animals
SRBCs were obtained from Yaohua Biotech Company (Shanghai, China) and prepared as described previously (15) . Mice were injected with 1 3 10 8 SRBCs through the vena caudalis. After 7 d, splenocytes were collected for surface and intracellular Ag analysis, and serum was collected for evaluation of Ag-specific Ab production. The control mice were injected with the same volume of saline.
Cell purification
CD4
+ T cells were purified from naive animals by magnetic depletion of B cells, macrophages, dendritic cells (DCs), NK cells, granulocytes, erythroid precursors, and CD8 + T cells (Miltenyi Biotec, Auburn, CA). CD62L + CD4
+ and CXCR5 + CD4 + T cells were further purified by magnetic separation using biotin-coupled CD62L (MEL-14; eBioscience, San Diego, CA) or CXCR5 (2G8; BD Biosciences, San Jose, CA) mAbs, respectively. Separation was performed on an autoMACS column using the Posseld program. Splenic B cells were isolated by positive selection with anti-CD19-coupled magnetic beads. DCs were matured from bone marrow following stimulation with 10 ng/ml GM-CSF and 5 ng/ml IL-4. After 6 d, cells were purified with anti-CD11c-coupled magnetic beads and stimulated with 500 ng/ml LPS (Sigma-Aldrich) for another 2 d. The purity of cell fractions in all experiments ranged between 90-98%, as estimated by flow cytometry using FACS (BD Biosciences, San Jose, CA).
Priming of naive T cells
Naive CD4 + CD62L + T cells (10 6 cells/well in 24-well plates) were preactivated for 72 h with plastic-coated CD3 mAb (145-2C11; 5 mg/ml) and CD28 mAb (37.51; 1 mg/ml). For differentiation of naive Th cells into T FH cells, naive cells were stimulated with CD3 mAb (5 mg/ml) and CD28 mAb (1 mg/ml) in the presence of IL-6 (5 ng/ml), IFN-g mAb (XMG1.2; 10 mg/ml), and IL-4 mAb (11B11; 10 mg/ml). T cells were recovered, washed extensively, and rested for 24 h in medium before being tested for cytokine secretion and B cell help capacity. In some experiments, cultured DC supernatants and/or 10 mg/ml neutralizing Abs to IL-12p40 (C17.8; eBioscience), IL-23p19 (G23-8; eBioscience), and IL-6 (MP5-20F3; eBioscience) were added to the culture. To evaluate T cell priming by DCs, activated DCs (1.3 3 10 3 cells/well) from WT or Il10rb 2/2 mice were cultured for 7 d with naive CD4 + T cells (4 3 10 4 cells/well) in RPMI 1640 complete medium. T FH cell differentiation in vitro was induced by the addition of rIL-6 (10 ng/ml) in the presence of IL-4 (10 mg/ml) and IFN-g (10 mg/ml) mAbs. In some experiments, rIL-10 was added to the culture to evaluate its role in inhibiting the differentiation of T FH cells. Polarization efficacy was verified by intracellular cytokine staining on secondary stimulations.
Flow cytometry
Anti-mouse mAbs marked with fluorescein were all purchased from eBioscience. Cells were washed with PBS containing 2% BSA (SigmaAldrich). FcgRs were blocked by incubation with CD16/CD32 mAb for 30 min at 4˚C. Cells were washed twice before being stained with FITCand PerCpCy5.5-conjugated anti-mouse cell surface molecule or intracellular Abs for 30 min at 4˚C in the dark. After staining, cells were washed with PBS/BSA before flow cytometry. Intracellular cytokines and transcription factors were stained with the BD Cytofix/Cytoperm Kit (BD Pharmingen) and Mouse Regulatory T Cell Staining Kit (eBioscience), respectively. Flow cytometric analysis was performed on a FACSCanto II (BD Biosciences) and analyzed with Diva software.
B cell help
Serial dilutions of CD4 + T cells were cultured for 7 d with purified syngeneic B cells (5 3 10 5 cells/well) in the presence of CD3 mAb or extracted SRBC membrane proteins. T cells were irradiated (2000 cGy) before the beginning of the coculture to prevent their outgrowth during the 7-d culture. IgM, IgG1, and IgG2a Abs in the supernatants were determined by ELISA, as previously described (16) . In some experiments, neutralizing Abs to IL-17 (TC11-8H4; BioLegend) and soluble IL-21R or isotype-matched controls were added (10 mg/ml) to the culture.
Quantitative RT-PCR
Total cellular RNA was extracted using TRIzol reagent, and reverse transcription of mRNA was carried out using moloney-murine leukemia virus reverse transcriptase (Invitrogen, Carlsbad, CA). Quantitative PCR was performed using an ABI Prism 5700 Sequence Detection System (Applied Biosystems, Foster City, CA). Quantitation, with b-actin as the endogenous reference gene, was performed using the 2 2DD method. Primer sequences can be obtained on request.
ELISA for SRBC-specific Abs and cytokines SRBC Abs in the serum were measured on day 21 by isotype-specific ELISA. Soluble SRBC Ags were prepared, as described previously (15) , and protein concentration was determined using the Bio-Rad Protein Assay reagent (Bio-Rad, Hercules, CA). Soluble SRBC Ags (5 mg/ml in carbonate buffer [pH 9.6]) were coated onto 96-well Immulon 2HB plates (Thermo Labsystems, Franklin, MA). After blocking with 1% (w/v) BSA in PBS, SRBC-specific IgM and IgG isotypes were determined by incubating serially diluted serum samples for 2 h at 37˚C. After washing with 0.05% (v/v) Tween 20 in PBS, wells were incubated with biotin-conjugated isotype-specific mAbs, including anti-mouse IgG1 (Serotec, Raleigh, NC) or anti-mouse IgG2b (BD Pharmingen, San Diego, CA), washed, and then developed with a VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA) and o-phenylenediamine (Wako, Osaka, Japan). After terminating the reaction with 2 N H 2 SO 4 , the optical densities at 490 and 595 nm were measured on a microplate reader (Bio-Rad). Supernatants from DC cultures were collected for ELISA detection of IL-6 (eBioscience), IL-12 (eBioscience), and IL-23 (eBioscience), according to the manufacturer's instructions.
Statistical analysis
The results are expressed as mean 6 SD from four mice in each group. Data were analyzed with SPSS software to calculate an unpaired, two-way Student t test, including an F test to compare variances. The p values , 0.05 were considered significant.
Results
Blockade of IL-10 promotes the B cell help function of activated Th cells IL-10 is known to induce activated B cell expansion and differentiation into Ab-producing cells that secrete a large amount of IgM, IgG, and IgA Abs (4, 5) . However, it is not clear whether IL-10 imparts its effects on Ab responses through regulation of Th cells. In these experiments, we first differentiated naive T cells into effector cells and then cocultured these effector cells with B cells. After several days in culture, the effects of these cells on B cell help were evaluated. Naive CD4 + CD62L + T cells were first stimulated in vitro by a combination of CD3 and CD28 mAbs, with or without IL-10. After a brief resting period, these cells were cocultured with purified CD19 + B cells from WT mice in the presence of anti-IgM for another 7 d. The ability of Th cells to provide B cell help was evaluated by examining the accumulation of IgG1 and IgG2a secretion in the supernatant at the end of the culture period. To our surprise, activated WT CD4 + T cells displayed inferior B cell help capacity compared with Il10rb 2/2 cells, and their effects were inhibited by added IL-10 ( Fig. 1A) . Because IL-6 was reported to drive the naive Th cell acquisition of B cell help functions and is dependent on T FH differentiation, we stimulated naive Th cells under T FH -polarizing conditions, with or without IL-10, and cocultured them with B cells, as described above. After 7 d, Th cells cultured under polarizing conditions produced more IgG than did those cultured under neutral conditions, and Il10rb 2/2 CD4 + T cells consistently displayed superior B cell help capacity compared with WT controls. As anticipated, IL-10 inhibited B cell help of Th cells, which were differentiated under T FH -polarizing conditions (Fig. 1B) .
Th cell IL-10 deprivation promotes thymus-dependent Ab production in vivo
The results described above suggested an inhibitory role for IL-10 in naive Th cell acquisition of B cell help functions, but it was still unknown whether this would affect Ab production in vivo. Using
The Journal of Immunology or not with IL-10, were immunized with SRBCs; 7 d later, the generation and B cell help function of CD4 + CXCR5 + cells in secondary lymphoid organs were analyzed. As anticipated, Il10rb 2/2 mice exhibited more CD4 + CXCR5 + cells in their spleens than did WT mice after immunization, and these cells within WT mice decreased when mice were pretreated with IL-10 ( Fig. 3A) . Staining for Bcl-6, the key transcription factor of T FH cells (17) 3B ) and specific Ab secretion (Fig. 3C) . We also found that T FH cells from IL-10-treated WT mice showed inferior B cell help capacities (Fig. 3C ). These data suggested that IL-10 controlled both the quantity and quality of T FH cells. mice were stimulated in vitro with SRBC membrane Ag for 24 h and then activated with PMA and ionomycin (IO) for another 5 h in the presence of brefeldin A (BFA). As described previously (24) (Fig. 4) . The results of flow cytometry were also confirmed by immunofluorescence of histological sections that IL-17-producing CD4 + cells existed either in or out of B cell follicle (Supplemental Fig. 1C) . In addition to IL-17 and IL-21, IL-10 has effects on IFN-g production, but the effects were mainly on CD4 + CXCR5 2 cells rather than on CD4 + CXCR5 + cells. It was in line with the report that IL-10 inhibits IFN-g production (25 Fig. 1D ). 
IL-10 signal-defective T FH cell-enhanced B cell help function in vivo is dependent on IL-21 and IL-17
To test the role of IL-21 and IL-17 in enhancing the B cell help function of T FH cells in vivo, we injected IL-17-neutralizing Abs, soluble IL-21R, or both into Il10rb 2/2 mice at the time of SRBC immunization, and these mice controlled by IgG-injected mice. Mice were sacrificed 7 d after immunization, and serum and splenocytes were collected. (Fig. 5B) . Anti-IL-17 was shown to have an effect on the generation of specific IgG, especially IgG2a, but it had no obvious effect on IgM production (Fig. 5A) . Additionally, anti-IL-17 impaired CD4 + CXCR5
+ cell production of IL-17 and IL-21 (Fig.  5B) . We also found an additive blockade effect of IL-17 and IL-21 on Ab production (Fig. 5A ) and T FH cell generation (Fig. 5B) . These results confirmed the previous observation that both IL-21 (13, 15) and IL-17 (26, 27) (Fig. 6D) . Therefore, IL-10 signal-defective DCs secrete soluble factors that control the differentiation of naive CD4 + T cells into IL-17-and IL-21-producing T FH cells.
IL-6 and IL-23 potently promote B cell help of T FH cells by increasing IL-21 and IL-17 secretion
To identify the cytokine(s) that regulate generation of IL-17 + IL-21 + CD4 + CXCR5 + cells, we first compared the RNA levels of some cytokines known to be expressed by DCs between Il10rb 2/2 and WT DCs after LPS activation. Quantitative RT-PCR showed a marked increase in Il-6, Il-1b, Tnf-a, Il-12p40, Il-12p35, and Il10, whereas little change was observed in Il-4, Il-27, and Tgf-b in both LPS-activated KO and WT DCs compared with resting cells. Next, we evaluated the levels of IL-6, IL-23p19, IL-10, and IL-12p70 in the supernatants of cultured DCs. Accordingly, Il10rb 2/2 DCs produced significantly higher levels of these cytokines than did WT controls after activation (Fig. 7A) 6 (Fig. 7C, upper panels) . Second, we primed naive cells with anti-CD3 and anti-CD28 in the presence of recombinant protein IL-6, IL-23, and/or IL-12 (Fig. 7C, lower panels) . Compared with allogeneic healthy control mice (age 6 wk), IBD mice (age 16 wk) showed significant inflammatory cell infiltration into the intestinal mucosa and disorganization of intestinal wall construction (Supplemental Fig. 2A ). Many more IL-17-producing cells were found in the mesenteric lymph nodes of Il10rb 2/2 mice at age 16 wk than in the same mice at age 6 wk (Supplemental Fig. 2B ). Intracellular staining (Supplemental Fig. 2C ) also showed greater amounts of IL-17-and IL-21-producing CD4 + CXCR5 + cells in mice of older age.
Discussion
IL-10 is a pleiotropic cytokine produced by multiple cell types that has an array of actions on T, B, NK, and myeloid cells (2) . Among its actions, IL-10 has immunostimulatory effects that augment the number of B cells activated via the BCR and costimulatory signals; however, it also has immunosuppressive properties related to its direct effects on Th cells and its ability to inhibit the production of multiple cytokines and chemokines (2, 28) . In polarized Th1 (25) and Th17 cells (29) , an IL-10 signal during activation of these cells is thought to be an important regulatory mechanism to avoid excessive immune responses. However, in T FH cells, the role of IL-10 was controversial. Early studies showed that T FH cells in tonsils with high expression of ICOS and CD45RO secreted moderate amounts of IL-10 (30), where it is crucial for costimulation in T and B cell collaboration. However, a recent study found that regulatory T cell-derived IL-10 reduced the production of autoimmune Abs in mouse lupus models by inhibiting IL-17-producing CD4 + CXCR5 + ICOS + cells (31) . Additionally, Chacón-Salinas et al. (32) demonstrated that mast cell-derived IL-10 affected T FH cell function and suppressed GC formation, a process associated with UV radiation-mediated immune suppression in skin cancer. Those studies outlined the complex role of IL-10 in T FH cell-mediated effects.
In this study, in vitro and in vivo experiments under conditions of both IL-10 sufficiency and deficiency clearly showed that IL-10 inhibited Ab responses by regulating T FH cells. The regulatory roles of IL-10 on T FH cells were mediated by at least two aspects: (18) (19) (20) , CD154 (21), OX40 (22) , and CD84 (23), than do other differentiated Th cell subsets. This reflects both the sustained multisignal integration required for T FH cell generation and their unique association with B cells (33) . The association of T and B cells was demonstrated to facilitate both eutopic and ectopic GC responses and then promote Ab production (33) . Furthermore, IL-10, as an inhibitor of some immune reactions, was described to regulate Th cells expressing costimulatory molecules (34) . Thus, we investigated whether the effects of IL-10 on T FH cell B cell help were mediated by regulating those costimulatory molecules. However, the superior B cell help function of Il10rb 2/2 T FH cells did not seem to be related to these molecules; no significant difference in either RNA or protein level of those molecules was found between Il10rb 2/2 and WT T FH cells.
In addition to costimulatory molecules, cytokines provide important signals for B cell help. T FH cells were found to produce a heterogeneous pattern of cytokines, such as IL-4, IL-10, IL-21, IFN-g, and IL-17. Among these cytokines, IL-21 was expressed most highly in T FH cells, which suggested a specialized role for IL-21 in T FH cells (33) . IL-21 not only had a crucial role in T FH cell differentiation, it also had a well-established role in B cell proliferation and differentiation (33) . In accordance with these findings, we showed that greater IL-21 secretion from IL-10 signal-defective T FH cells could lead to increased Ig production. This suggested that T FH cell-mediated immune effects were regulated by inhibitory features of IL-10 on its distinctive cytokine, IL-21, similar to the way in which IL-10 regulates Th1-and Th17-mediated immune responses by inhibiting IFN-g and IL-17.
In addition to IL-21, other cytokines played important roles in B cell differentiation and/or shaping the Ab repertoire. IFN-g and IL-4 secreted from T FH cells were demonstrated to shape the Ab repertoire (35) , and IL-17 was also reported to be capable of inducing B cell activation (26, 27 ). In the current study, intracellular staining of splenocytes did not show any definitive IFN-g-or IL-4-producing CD4 + CXCR5 + cells, but moderate IL-17-producing CD4 + CXCR5 + cells were found in immunized Il10rb 2/2 mice.
Moreover, these IL-17-producing CD4 + CXCR5 + cells also produced IL-21. As anticipated, IL-17 secreted by these cells was not only involved in B cell help, but also added the effects of IL-21 on B cell help, which suggests that the superior ability of Il10rb
2/2
T FH cells to provide B cell help was not completely dependent on IL-21 signaling. The observation that IL-17-producing T FH cells were controlled by IL-10 was also consistent with the finding in Icos 2/2 mice, in which the presence of IL-17-producing CD4 + CXCR5 + cells in the spleen and draining lymph nodes was related to a decrease in IL-10-producing regulatory T cells (20) .
The cellular interactions underlying T FH differentiation are not fully elucidated, but they appear to involve sequential priming on DCs. IFN-a/b (36) and IL-6 (37) were demonstrated to stimulate mouse T FH cell differentiation, and so did IL-12 (38) to human T FH , and those signals in DCs were important for the effect. In this study, we first demonstrated that DC signals contributed to the generation of IL-17-producing T FH cells when there was an IL-10 deficiency and then observed an increase in the secretion of IL-6 and IL-23 by DCs associated with this process. Because previous reports described crucial roles for IL-6 and IL-23 in the induction and expansion of Th17 cells (29, 39, 40) + CD4 + T cells contain specific subsets, including Th1, Th2, and Th17, which differentially supports Ab secretion (38) . However, a more detailed study is needed to determine their developmental relationship, because IL-6 and IL-23 did not appear to increase CXCR5 expression.
In many inducible and spontaneous autoimmune models (20, 41) , IL-17-producing T FH cells could be found in the spleen or draining lymph nodes. In this study, we found that IL-17-producing T FH cells accumulated in the spleen of immunized Il10rb 2/2 mice, as well as in the mesenteric lymph nodes of Il10rb 2/2 mice during spontaneous IBD. It is possible that such IL-17-producing T FH cells played roles in the pathogenesis of IBD in IL-10 signaling-deficient mice. Thus, our study may provide an explanation for the relationship between IL-10 and IBD. In summary, our study indicated that IL-10, which was traditionally regarded as a costimulator of Ab production, could also inhibit Ab responses indirectly through regulating a subset of T FH cells that produces IL-17 and IL-21. The IL-17-producing T FH cells promoted Ab production, and their generation was related to IL-6 and IL-23 signaling in DCs. Thus, to our knowledge, our study is the first to demonstrate a complex role for IL-10 in Ab production. Additionally, because IL-17-producing cells are related to many diseases, including IBD, our study may assist in the development of treatment for such diseases.
